MERS CoV

NIH Monkeypox Smuggling Release, pp.9-11 · monkeypox_release:email:00008

Page text: p.9, p.10, p.11 · original PDF

Date: 2013-06-25 09:41
Type: email · email
cc: COL Usarmy Medcom Afhsc
to: J CDR Usarmy Medcom Afhsc
Topics: Intelligence community assessments

This text appears inside a quoted reply chain — it is evidence that the message was circulating, not necessarily a new message.

Dear - The Jordan isolate that we received from N3 grew well in cell culture, so we are preparing to begin some experiments. Thank you for your help in getting this virus. From the email correspondence with Dr. Lisa Hensley at the NIAID IRF in Frederick, I understood that we had your permission to share the virus with her. >< Several other people have been asking whether they can get an aliquot. I am including their names and affiliations below: Ralph Baric, Univ of North Carolina Mark Denison, Vanderbilt Univ Matthew Frieman, Univ of Maryland Vincent Munster, NIAID Rocky Mountain Lab All of these investigators have BSL3 (or BSL4 in the case of RML) labs and are experienced virologists. Please let me know if I can direct them to you for permission. I would be happy to ship the virus to them if you cc me. Thank you again. Please let me know if there are projects that we could work on together. Is there an effort to do some serosurveys in members of the military who have been stationed in the region? Best wishes, Kanta -- Kanta Subbarao, MD, MPH Chief, Emerging Respiratory Viruses Section Laboratory of Infectious Phone: Fax: Email: @niaid.nih.gov<mailto: @niaid.nih.gov><mailto: @niaid.nih.gov> ******************************************* The information in this e-mail and any of its attachments is confidential and may contain sensitive information. It should not be used by anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender and delete it from your mailbox or any other storage devices. National Institute of Allergy and Infectious Diseases shall not accept liability for any statements made that are sender's own and not expressly made on behalf of the NIAID by one of its representatives. ******************************************* Classification: UNCLASSIFIED Caveats: NONE Amy C. Sims, Ph.D. Office:ee (@ad.unc.edu<mailto {i @ad.unc.edu><mailto fi @ad.unc.edu> Amy C. Sims, Ph.D. Office:ee (@ad.unc.edu<mailto {i @ad.unc.edu><mailto fi @ad.unc.edu> Amy C. Sims, Ph.D. Office:ee (ad unc edu<mailto I @ad.uncedu> Amy C. Sims, Ph.D. Office: ad.unc.edu

In context

A single line often inverts meaning once you see what it answers, so neighbouring messages are always shown.

2013-06-25 09:41 unattributed

Dear - The Jordan isolate that we received from N3 grew well in cell culture, so we are preparing to begin some experiments. Thank you for your help in getting this virus. From the email correspondence with Dr. Lisa Hensley at the NIAID IRF in Frederick, I understood that we had your permission to share the virus with her. >< Several other people have been asking whether they can get an aliquot. I am including their names and affiliations below: Ralph Baric, Univ of North Carolina Mark Denison, Vanderbilt Univ Matthew Frieman, Univ of Maryland Vincent Munster, NIAID Rocky Mountain Lab All of these investigators have BSL3 (or BSL4 in the case of RML) labs and are experienced virologists. Please let me know if I can direct them to you for permission. I would be happy to ship the virus to them if you cc me. Thank you again. Please let me know if there are projects that we could work on together. Is there an effort to do some serosurveys in members of the military who have been stationed in the region? Best wishes, Kanta -- Kanta Subbarao, MD, MPH Chief, Emerging Respiratory Viruses Section Laboratory of Infectious Phone: Fax: Email: @niaid.nih.gov<mailto: @niaid.nih.gov><mailto: @niaid.nih.gov> ******************************************* The information in this e-mail and any of its attachments is confidential and may contain sensitive information. It should not be used by anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender and delete it from your mailbox or any other storage devices. National Institute of Allergy and Infectious Diseases shall not accept liability for any statements made that are sender's own and not expressly made on behalf of the NIAID by one of its representatives. ******************************************* Classification: UNCLASSIFIED Caveats: NONE Amy C. Sims, Ph.D. Office:ee (@ad.unc.edu<mailto {i @ad.unc.edu><mailto fi @ad.unc.edu> Amy C. Sims, Ph.D. Office:ee (@ad.unc.edu<mailto {i @ad.unc.edu><mailto fi @ad.unc.edu> Amy C. Sims, Ph.D. Office:ee (ad unc edu<mailto I @ad.uncedu> Amy C. Sims, Ph.D. Office: ad.unc.edu
2013-07-29 17:51 Amy C Sims open

Hi, This is Amy Sims from the Baric lab. I've attached the CDC import permit form filled out for us to acquire the Jordan strain of MERS-CoV. Would you please review it and make sure that I haven't made any errors? Also, UNC's EHS requires that we receive the virus as a category A infectious shipment. Is there anything I can do to help with the shipment? Do you need anything else from me while we wait for the permit to be approved? Thank you, Amy
2013-08-23 14:48 Amy C Sims open

All, I finally got our CDC import permit approved. It is attached. We would like to obtain the Jordan isolate of MERS-CoV at your earliest convenance. 'Vogel, Leatrice >> Also, please note that as the virus has been amplified in a laboratory setting UNC's Environmental Health and Safety office requires that the virus be shipped as a category A infectious substance. We can provide shipping materials if need be but the virus must be shipped with this documentation. I mention this as the shipment to Vanderbilt went category B. Our Fedex number is and if the following could be added as the customer number or PO that would be great! If you have any questions please let me know. Thank you so much! Amy

Full conversation →